Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer.
Se Young ChoiByung Hoon ChiBumjin LimYoon Soo KyungDalsan YouIn Gab JeongCheryn SongJun Hyuk HongHanjong AhnChoung-Soo KimPublished in: Journal of cancer research and clinical oncology (2020)
The 7th edition pathologic T2 subclassification had poor prognostic value for biochemical recurrence in our cohort. Elimination of the 8th edition subclassification was suitable. Percent tumor volume classified biochemical recurrence prognosis in pathologic T2 stage. Therefore, percent tumor volume can be a candidate factor for the next T2 subclassification.